Mano Joseph

Gheskio Centers — HT

Medicine · Health Sciences

4h-index2.9kcitations17works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(6), Colorectal Cancer Treatments and Studies(5), Head and Neck Cancer Studies(3), Esophageal Cancer Research and Treatment(3), Lung Cancer Treatments and Mutations(2)

Publications15 total

Advanced Detection for Breast Cancer Using Ring Resonator Biosensors Coupled with Support Vector Machine
2025
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial
The Lancet HIV·2025· 3 cited
134eP Observed survival following treatment with leronlimab in patients with metastatic colorectal cancer
Annals of Oncology·2025
369P Observed survival following treatment with Leronlimab in patients with metastatic triple-negative breast cancer (mTNBC)
ESMO Open·2025· 2 citedOpen Access
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Ritonavir-Boosted Protease Inhibitor-Based Antiretroviral Therapy in Persons with HIV and Viral Suppression on Second-Line Therapy: An Open-Label Randomized Non-Inferiority Trial
SSRN Electronic Journal·2025Open Access
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies
Cancers·2022· 1 citedOpen Access
1389P Real world outcomes of locally advanced gastric/GOJ cancers receiving perioperative chemotherapy with FLOT regimen during the COVID-19 pandemic: Results from a regional cancer care centre in the UK
Annals of Oncology·2021Open Access
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
JAMA Oncology·2021· 176 citedOpen Access
Optimising Chemotherapy for Frail and Older Patients With Advanced Gastroesophageal Cancer: The GO2 Phase III Trial
SSRN Electronic Journal·2020· 1 citedOpen Access
OPTIMIZING CHEMOTHERAPY FOR FRAIL AND/OR ELDERLY PATIENTS WITH ADVANCED GASTROESOPHAGEAL CANCER (AGOAC): THE GO2 PHASE III TRIAL
Journal of Geriatric Oncology·2019· 3 cited
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
The Lancet·2018· 1.6k citedOpen Access
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
The Lancet·2018· 989 citedOpen Access
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
European Journal of Cancer·2018· 31 citedOpen Access
Ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Secondary analysis of efficacy and safety results of 4 dosing regimens in the phase II trial I4T-MC-JVDB.
Journal of Clinical Oncology·2018· 2 cited
A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB
Annals of Oncology·2017· 4 citedOpen Access

Frequent Co-authors

Kevin J. Harrington(5), Daniel Swinson(5), Mererid Evans(4), Devraj Srinivasan(3), Audrey Cook(3), Emma De Winton(3), David A. Cairns(3), Christine Allmark(3), Sharon Ruddock(3), Jonathan Wadsley(3), Tania Tillett(3), J. J. Nicoll(3), Simon Grumett(3), Zuzana Stokes(3), Jaffer A. Ajani(3), Anghel Adrian Udrea(3), Tomasz Sarosiek(3), Carys Morgan(3), Joanna Pikiel(3), Tomáš Šálek(3)